Security key
05153U107
Aura Biosciences, Inc. - Common Stock, par value $0.00001 per share (AURA)
CUSIP: 05153U107
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, par value $0.00001 per share
- Shares outstanding
- 96,296,293
- Total 13F shares
- 50,616,053
- Share change
- +10,745,541
- Total reported value
- $316,863,119
- Price per share
- $6.26
- Number of holders
- 102
- Value change
- +$67,408,487
- Number of buys
- 55
- Number of sells
- 43
Report period
Q2 2025
Institutions
102
Top holders
10
AURA full security history
Newer quarter: Q3 2025
Previous quarter: Q1 2025
Aura Biosciences, Inc. SEC filings
Aura Biosciences, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 05153U107
Recent filing periods:
Top shareholders of AURA - Aura Biosciences, Inc. - Common Stock, par value $0.00001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13D/G
13F
|
Company |
7.6%
|
4,701,775
|
$30,091,360 | +$10,524,518 | 30 Jun 2025 | |
| Long Focus Capital Management, LLC |
13F
13D/G
|
Company |
6.6%
from 13D/G
|
3,319,582
|
$19,452,751 | — | 31 Mar 2025 | |
| Matrix Capital Management Company, LP |
13F
|
Company |
7.2%
|
6,922,870
|
$40,568,018 | — | 31 Mar 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
5.1%
|
4,881,125
|
$28,603,393 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
3.7%
|
3,539,948
|
$20,744,095 | — | 31 Mar 2025 | |
| Medicxi Ventures Management (Jersey) Ltd |
13F
3/4/5
|
Company · 10%+ Owner |
3.2%
|
3,039,892
|
$17,813,767 | — | 31 Mar 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
2.3%
|
2,210,589
|
$12,954,051 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
2%
|
1,952,333
|
$11,440,671 | — | 31 Mar 2025 | |
| LEVIN CAPITAL STRATEGIES, L.P. |
13F
|
Company |
1.4%
|
1,360,768
|
$7,974,100 | — | 31 Mar 2025 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
1.3%
|
1,267,697
|
$7,428,704 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.1%
|
1,025,556
|
$6,011,077 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.82%
|
793,011
|
$4,647,044 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.78%
|
753,158
|
$4,413,506 | — | 31 Mar 2025 | |
| Regency Capital Management Inc.\DE |
13F
|
Company |
0.78%
|
749,482
|
$4,391,965 | — | 31 Mar 2025 | |
| ACORN CAPITAL ADVISORS, LLC |
13F
|
Company |
0.61%
|
590,508
|
$1,453,362 | — | 31 Mar 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.54%
|
519,785
|
$3,047,000 | — | 31 Mar 2025 | |
| Decheng Capital LLC |
13F
|
Company |
0.54%
|
515,555
|
$3,021,152 | — | 31 Mar 2025 | |
| B Group, Inc. |
13F
|
Company |
0.49%
|
472,576
|
$2,769,295 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.42%
|
405,926
|
$2,380,068 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.39%
|
374,518
|
$2,194,674 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.17%
|
164,041
|
$961,281 | — | 31 Mar 2025 | |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
|
Company |
0.17%
|
162,358
|
$951,418 | — | 31 Mar 2025 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.16%
|
151,108
|
$885,493 | — | 31 Mar 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.14%
|
138,952
|
$814,259 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.14%
|
138,466
|
$811,411 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.13%
|
121,644
|
$712,834 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.11%
|
107,051
|
$627,318 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.11%
|
103,300
|
$605,338 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.1%
|
99,447
|
$582,759 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.1%
|
95,706
|
$560,838 | — | 31 Mar 2025 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.07%
|
69,030
|
$404,516 | — | 31 Mar 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.07%
|
64,493
|
$377,930 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.07%
|
64,038
|
$375,256 | — | 31 Mar 2025 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.06%
|
62,389
|
$365,600 | — | 31 Mar 2025 | |
| TBH Global Asset Management, LLC |
13F
|
Company |
0.06%
|
60,322
|
$353,489 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.06%
|
57,384
|
$336,270 | — | 31 Mar 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.05%
|
51,657
|
$302,710 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.05%
|
50,395
|
$295,315 | — | 31 Mar 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.04%
|
38,604
|
$226,219 | — | 31 Mar 2025 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.04%
|
37,156
|
$217,734 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.03%
|
32,865
|
$192,589 | — | 31 Mar 2025 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.03%
|
31,560
|
$185,000 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.03%
|
31,284
|
$183,324 | — | 31 Mar 2025 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.03%
|
30,278
|
$177,000 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
0.03%
|
29,644
|
$173,714 | — | 31 Mar 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.03%
|
28,239
|
$165,481 | — | 31 Mar 2025 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.03%
|
27,738
|
$162,545 | — | 31 Mar 2025 | |
| MetLife Investment Management, LLC |
13F
|
Company |
0.03%
|
27,337
|
$160,195 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.03%
|
26,123
|
$153,081 | — | 31 Mar 2025 | |
| HARBOR CAPITAL ADVISORS, INC. |
13F
|
Company |
0.03%
|
25,741
|
$151,000 | — | 31 Mar 2025 |
Institutional Holders of Aura Biosciences, Inc. - Common Stock, par value $0.00001 per share (AURA) as of Q2 2025
As of 30 Jun 2025,
Aura Biosciences, Inc. - Common Stock, par value $0.00001 per share (AURA) was held by
102 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
50,616,053 shares.
The largest 10 holders included
Matrix Capital Management Company, LP, Frazier Life Sciences Management, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C., Long Focus Capital Management, LLC, SUVRETTA CAPITAL MANAGEMENT, LLC, BlackRock, Inc., Medicxi Ventures Management (Jersey) Ltd, VANGUARD GROUP INC, FRANKLIN RESOURCES INC, and Nantahala Capital Management, LLC.
This page lists
102
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
91
Q2 2025 holders
102
Holder diff
11
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.